The host cytokine responses and protective immunity in oropharyngeal candidiasis

Journal of Dental Research

Volumn 84, Issue 11, 2005, Pages 966-977

  Dongari Bagtzoglou, A ^a   Fidel Jr , P L ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cytokines; Immune response; Oral candidiasis

Indexed keywords

CYTOKINE;

ANTIBODY PRODUCTION; CANDIDIASIS; CELLULAR IMMUNITY; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MOUTH MUCOSA; MUCOSAL IMMUNITY; PHARYNX DISEASE; REVIEW; SIGNAL TRANSDUCTION;

ANTIBODY FORMATION; CANDIDIASIS; CYTOKINES; EPITHELIAL CELLS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; MOUTH MUCOSA; PHARYNGEAL DISEASES; SIGNAL TRANSDUCTION;

EID: 33644639433     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508401101     Document Type: Review

References (113)

1. Allendoerfer R, Magee DM, Smith JG, Bonewald L, Graybill JR (1993). Induction of tumor necrosis factor-alpha in murine Candida albicans infection. J Infect Dis 167:1168-1172.
2. Arancia G, Molinari A, Crateri P, Stringaro A, Ramoni C, Dupuis ML, et al. (1995). Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect Immun 63:280-288.
3. Ashman RB, Papadimitriou JM (1995). Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 59:646-672.
4. Axéll T, Samaranayake LP, Reichart PA, Olsen I (1997). A proposal for reclassification of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:111-112.
5. Baggiolini M, Walz A, Kunkel SL (1989). Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049.
6. Balish E, Warner T, Pierson CJ, Bock DM, Wagner RD (2001). Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med Mycol 39:261-268.
7. Beno DW, Stover AG, Mathews HL (1995). Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol 154:5273-5281.
8. Black KP, Merrill KW, Jackson S, Katz J (2000). Cytokine profiles in parotid saliva from HIV-1-infected individuals: changes associated with opportunistic infections in the oral cavity. Oral Microbiol Immunol 15:74-81.
9. Blanch VJ, Piskurich JF, Kaetzel CS (1999). Cutting edge: coordinate regulation of IFN regulatory factor-1 and the polymeric Ig receptor by pro-inflammatory cytokines. J Immunol 162:1232-1235.
10. Blanchard DK, Michelini-Norris MB, Djeu JY (1991). Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood 77:2259-2265.
11. Brandtzaeg P, Gabrielsen TO, Dale I, Muller F, Steinbakk M, Fagerhol MK (1995). The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 371(A):201-206.
12. Braun BR, Johnson AD (1997). Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105-109.
13. Brettle RP (1997). Bacterial infections in HIV: the extent and nature of the problem. Int J STD AIDS 8:5-15.
14. Challacombe SJ (1994). Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 78:202-210.
15. Clemons KV, Stevens DA (2001). Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy. Semin Respir Infect 16:60-66.
16. Coffey MJ, Phare SM, George S, Peters-Golden M, Kazanjian PH (1998). Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J Clin Invest 102:663-670.
17. Colon MD, Toledo N, Valiente CL, Rodriguez N, Yano N, Mathews H, et al. (1998). Anti-fungal and cytokine producing activities of CD8+ T lymphocytes from HIV-1 infected individuals. Bol Asoc Med PR 90:21-26.
18. Coogan MM, Sweet SP, Challacombe SJ (1994). Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 62:892-896.
19. Cox DT, Allen CM, Plouffe JF (1996). Locally invasive oral candidiasis mimicking zygomycosis in a patient with diabetic ketoacidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:70-73.
20. Csato M, Kenderessy AS, Judak R, Dobozy A (1990). Inflammatory mediators are involved in the Candida albicans killing activity of human epidermal cells. Arch Dermatol Res 282:348-350.
21. Dale BA, Kimball JR, Krisanaprakornkit S, Roberts F, Robinovitch M, O'Neal R, et al. (2001). Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 36:285-294.
22. Deslauriers N, Coulombe C, Carré B, Goulet JP (1995). Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans. FEMS Immunol Med Microbiol 11:45-55.
23. Deslauriers N, Cote L, Montplaisir S, de Repentigny L (1997). Oral carriage of Candida albicans in murine AIDS. Infect Immun 65:661-667.
24. Dieterich C, Schandar M, Noll M, Johannes FJ, Brunner H, Graeve T, et al. (2002). In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion. Microbiology 148:497-506.
25. Dinarello CA (1997). Interleukin-1. Cytokine Growth Factor Rev 8:253-265.
26. Djeu JY, Blanchard DK (1987). Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol 139:2761-2767.
27. Dongari-Bagtzoglou A, Kashleva H (2003a). Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog 34:169-177.
28. Dongari-Bagtzoglou A, Kashleva H (2003b). Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol Immunol 18:165-170.
29. Dongari-Bagtzoglou A, Wen K, Lamster IB (1999). Candida albicans triggers IL-6 and IL-8 responses by oral fibroblasts in vitro. Oral Microbiol Immunol 14:364-370.
30. Dongari-Bagtzoglou A, Kashleva H, Villar CC (2004). Bioactive interleukin-1α is cytolytically released from Candida albicans-infected oral epithelial cells. Med Mycol 42:531-541.
31. Dongari-Bagtzoglou A, Kashleva H, Villar CC (2005). Oral epithelial cells activate neutrophil antifungal activities in vitro. Med Mycol (in press).
32. Drobacheff C, Millon L, Monod M, Piarroux R, Robinet E, Laurent R, et al. (2001). Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clin Chem Lab Med 39:519-526.
33. Elahi S, Pang G, Clancy R, Ashman RB (2000). Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect Immun 68:5771-5777.
34. Ellis M, Gupta S, Galant S, Hakim S, VandenVen C, Toy C, et al. (1988). Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis 158:1268-1275.
35. Epstein JB, Kimura LH, Menard TW, Truelove EL, Pearsall NN (1982). Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Arch Oral Biol 27:469-474.
36. Epstein JB, Hancock PJ, Nantel S (2003). Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:154-163.
37. Eversole LR, Reichart PA, Ficarra G, Schmidt-Westhausen A, Romagnoli P, Pimpinelli N (1997). Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:372-380.
38. Farah CS, Elahi S, Pang G, Gotjamanos T, Seymour GJ, Clancy RL, et al. (2001). T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect Immun 69:6110-6118.
39. Farah CS, Elahi S, Drysdale K, Pang G, Gotjamanos T, Seymour GJ, et al. (2002a). Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis. Infect Immun 70:724-731.
40. Farah CS, Gotjamanos T, Seymour GJ, Ashman RB (2002b). Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol Immunol 17:375-378.
41. Fidel PL Jr (2002a). Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol 40:359-375.
42. Fidel PL Jr (2002b). The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models. Int Rev Immunol 21:515-548.
43. Fidel PL Jr (2004). History and new insights into host defense against vaginal candidiasis. Trends Microbiol 12:220-227.
44. Goodrum KJ, Poulson-Dunlap J (2002). Cytokine responses to group B streptococci induce nitric oxide production in respiratory epithelial cells. Infect Immun 70:49-54.
45. Hahn BL, Sohnle PG (1988). Characteristics of dermal invasion in experimental cutaneous candidiasis of leucopenic mice. J Invest Dermatol 91:233-237.
46. Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, et al. (2003). CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 170:1452-1461.
47. Johansen F-E, Brandtzaeg P (2004). Transcriptional regulation of the mucosal IgA system. Trends Immunol 25(3):150-157.
48. Katou F, Ohtani H, Nakayama T, Ono K, Matsushima K, Saaristo A, et al. (2001). Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. Am J Pathol 158:1263-1270.
49. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ, Matsushima K (1990). Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci USA 87:5548-5552.
50. Krisanaprakornkit S, Jotikasthira D, Dale BA (2003). Intracellular calcium in signaling human beta-defensin-2 expression in oral epithelial cells. J Dent Res 82:877-882.
51. Kunkl A, Mortara L, Valle MT, Fenoglio D, Terranova MP, Megiovanni AM, et al. (1998). Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons. J Infect Dis 178:488-496.
52. Lamy M, Mojon P, Kalykakis G, Legrand R, Budtz-Jorgensen E (1999). Oral status and nutrition in the institutionalized elderly. J Dent 27:443-448.
53. Lehrer RI, Cline MJ (1969). Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48:1478-1488.
54. Leigh JE, Steele C, Wormley FL Jr, Luo W, Clark RA, Gallaher W, et al. (1998). Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acquir Immune Defic Syndr Hum Retrovirol 19:373-380.
55. Leigh JE, Barousse M, Swoboda RK, Myers T, Hager S, Wolf NA, et al. (2001). Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis. J Infect Dis 183:277-285.
56. Leigh JE, Steele C, Wormley F, Fidel PL Jr (2002). Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol Immunol 17:311-314.
57. Lilly EA, Hart DJ, Leigh JE, Hager S, McNulty KM, Mercante DE, et al. (2004). Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis. J Infect Dis 190:605-612.
58. Liu Y, Buhring HJ, Zen K, Burst SL, Schnell FJ, Williams IR, et al. (2002). Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem 277:10028-10036.
59. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR (1997). Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
60. + cells and microenvironment in oral lesions of HIV-infected persons with oropharyngeal candidiasis. Infect Immun 73:3659-3667.
61. Meyer CN, Nielsen H (1996). Priming of neutrophil and monocyte activation in HIV infection. APMIS 104:640-646.
62. Mostefaoui Y, Bart C, Frenette M, Rouabhia M (2004a). Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells. Cell Microbiol 6:1085-1096.
63. Mostefaoui Y, Claveau I, Rouabhia M (2004b). In vitro analyses of tissue structure and interleukin-1beta expression and production by human oral mucosa in response to Candida albicans infections. Cytokine 25:162-171.
64. Murphy PM, Lane CH, Fauci AS, Gallin JI (1988). Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 158:627-631.
65. Myers TA, Leigh JE, Arribas AR, Hager S, Clark R, Lilly E, et al. (2003). Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis. Infect Immun 71:956-963.
66. Myoken Y, Sugata T, Fujita Y, Kohara T, Mikami Y (2004). Oropharyngeal Candida colonization and infection in neutropenic patients with hematologic malignancies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:137-138; author reply 138.
67. Netea MG, van Tits LJ, Curfs JH, Amiot F, Meis JF, van der Meer JW, et al. (1999). Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 163:1498-1505.
68. Nielsen H, Kharazmi A, Faber V (1986). Blood monocyte and neutrophil functions in the Acquired Immune Deficiency Syndrome. Scand J Immunol 24:291-296.
69. Nomanbhoy F, Steele C, Yano J, Fidel PL Jr (2002). Vaginal and oral epithelial cell anti-Candida activity. Infect Immun 70:7081-7088.
70. O'Grady JF, Reade PC (1993). Role of thermal trauma in experimental oral mucosal Candida infections in rats. J Oral Pathol Med 22:132-137.
71. Odds FC (1988). Candida and candidosis: a review and bibliography. London, UK: Bailliere Tindale.
72. Olsen I, Haanaes HR (1977). Experimental palatal candidiosis and saliva flow in monkeys. Scand J Dent Res 85:135-141.
73. Orozco AS, Zhou X, Filler SG (2000). Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect Immun 68:1134-1141.
74. Parkos CA (1997). Cell adhesion and migration. I. Neutrophil adhesive interactions with intestinal epithelium. Am J Physiol 273:G763-G768.
75. Perregaux DG, Gabel CA (1998). Human monocyte stimulus-coupled IL-1beta posttranslational processing: modulation via monovalent cations. Am J Physiol 275:C1538-C1547.
76. Pitrak DL, Bak PM, DeMarais P, Novak RM, Andersen BR (1993). Depressed neutrophil superoxide production in HIV infection. J Infect Dis 167:1406-1410.
77. Radyuk SN, Mericko PA, Popova TG, Grene E, Alibek K (2003). In vitro- generated respiratory mucosa: a new tool to study inhalational anthrax. Biochem Biophys Res Commun 305:624-632.
78. Redding SW (2001). The role of yeasts other than Candida albicans in oropharyngeal candidiasis. Curr Opin Infect Dis 14:673-677.
79. Redding SW, Zellars RC, Kirkpatrick WR, McAtee RK, Caceres MA, Fothergill AW, et al. (1999). Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37:3896-3900.
80. Redding SW, Kirkpatrick WR, Coco BJ, Sadkowski L, Fothergill AW, Rinaldi MG, et al. (2002). Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol 40:1879-1881.
81. Reichart PA, Philipsen HP, Schmidt-Westhausen A, Samaranayake LP (1995). Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings. J Oral Pathol Med 24:276-281.
82. Rocha B, Vassalli P, Guy-Grand D (1994). Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J Exp Med 180:681-686.
83. Rodriguez-Adrian LJ, Grazziutti ML, Rex JH, Anaissie EJ (1998). The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed? Clin Infect Dis 26:1270-1278.
84. Roilides E, Mertins S, Eddy J, Walsh TJ, Pizzo PA, Rubin M (1990). Impairment of neutrophil chemotactic and bactericidal function in children infected with HIV type 1 and partial reversal after in vitro exposure to GM-CSF. J Pediatrics 117:531-540.
85. Roilides E, Lamaignère CG, Farmaki E (2002). Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy. Int J Infect Dis 6:154-163.
86. Romagnoli P, Pimpinelli N, Mori M, Reichart PA, Eversole LR, Ficarra G (1997). Immunocompetent cells in oral candidiasis of HIV-infected patients: an immunohistochemical and electron microscopical study. Oral Dis 3:99-105.
87. Romani L (2004). Immunity to fungal infections. Nat Rev Immunol 4:1-23.
88. Rouabhia M, Ross G, Page N, Chakir J (2002). Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect Immun 70:7073-7080.
89. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL (2003). Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2:1053-1060.
90. Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B, Korting HC (2002). Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 118:652-657.
91. Schaller M, Boeld U, Oberbauer S, Hamm G, Hube B, Korting HC (2004). Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 150:2807-2813.
92. Scully C, el-Kabir M, Samaranayake LP (1994). Candida and oral candidosis: a review. Crit Rev Oral Biol Med 5:125-157.
93. Sitheeque MA, Samaranayake LP (2003). Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 14:253-267.
94. Sohnle PG, Collins-Lech C, Wiessner JH (1991). The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis 164:137-142.
95. Steele C, Fidel PL Jr (2002). Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 70:577-583.
96. Steele C, Leigh J, Swoboda R, Fidel PL Jr (2000). Growth inhibition of Candida by human oral epithelial cells. J Infect Dis 182:1479-1485.
97. Steele C, Leigh J, Swoboda R, Ozenci H, Fidel PL Jr (2001). Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect Immun 69:7091-7099.
98. Steinshamn S, Waage A (1992). Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 60:4003-4008.
99. Takakura N, Wakabayashi H, Ishibashi H, Yamauchi K, Teraguchi S, Tamura Y, et al. (2004). Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 53:495-500.
100. Tanida T, Ueta E, Tobiume A, Hamada T, Rao F, Osaki T (2001). Influence of aging on candidal growth and adhesion regulatory agents in saliva. J Oral Pathol Med 30:328-335.
101. Tardif F, Goulet JP, Zakrazewski A, Chauvin P, Rouabhia M (2004). Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis. Med Sci Monit 10:BR239-249.
102. Tosi MF, Hamedani A, Brosovich J, Alpert SE (1994). ICAM-1-independent, CD18-dependent adhesion between neutrophils and human airway epithelial cells exposed in vitro to ozone. J Immunol 152:1935-1942.
103. Ueta E, Osaki T, Yoneda K, Yamamoto T (1993). Functions of salivary polymorphonuclear leukocytes (SPMNs) and peripheral blood polymorphonuclear leukocytes (PPMNs) from healthy individuals and oral cancer patients. Clin Immunol Immunopathol 66:272-278.
104. Ueta E, Tanida T, Doi S, Osaki T (2000). Regulation of Candida albicans growth and adhesion by saliva. J Lab Clin Med 136:66-73.
105. Vazquez JA, Hidalgo JA, De Bono S (2000). Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study. HIV Clin Trials 1:23-29.
106. Villar CC, Kashleva H, Dongari-Bagtzoglou A (2004). Role of Candida albicans polymorphism in the interactions with oral epithelial cells. Oral Microbiol Immunol 19:262-269.
107. Villar CC, Kashleva H, Mitchell AP, Dongari-Bagtzoglou A (2005). Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect Immun 73:4588-4595.
108. Warris A, Bjornklett A, Gaustad P (2001). Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 344:1099-1100.
109. Wozniak KL, Leigh JE, Hager S, Swoboda RK, Fidel PL Jr (2002). A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. J Infect Dis 185:1269-1276.
110. Wray D, Felix DH, Cumming CG (1990). Alteration of humoral responses to Candida in HIV infection. Br Dent J 168:326-329.
111. + intestinal intraepithelial lymphocytes in rats. Int Immunol 11:21-28.
112. Yano J, Lilly E, Steele C, Fortenberry D, Fidel PL (2005). Oral and vaginal epithelial cell anti-Candida activity is acid-labile and does not require live epithelial cells. Oral Microbiol Immunol 20:199-205.
113. Zunino SJ, Hudig D (1988). Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Infect Immun 56:564-569.